BackLAW
Lorna Hajdini sued: JPMorgan reacts over bombshell assault allegations | A look at victim's demands
A lawsuit in New York accuses Lorna Hajdini, a JPMorgan executive director, of sexual harassment, coercion, drugging, and racial abuse of a junior employee. The complaint alleges a sustained pattern beginning after March 2024, with claims including non-consensual acts and allegations of Rohypnol use; JPMorgan publicly denies merit while the plaintiff seeks damages and reforms.
Why It Matters
The case involves serious allegations against a senior JPMorgan executive and could affect corporate governance, workplace conduct policies, and investor confidence.
Timeline
2 Events
Lawsuit filed and JPMorgan response reported
April 30, 2026
The article reports that a lawsuit was filed in New York County Supreme Court accusing Lorna Hajdini of sexual harassment, coercion, drugging, sexual assault, and racial abuse. The complaint describes unwanted advances, threats to the victim's career, and alleged drugging with Rohypnol and other substances. The victim, described as an Asian male employee, seeks emotional, wage, and reputational damages, punitive damages, and internal policy changes. JPMorgan issued a statement denying merit after an investigation, noting the complainant refused to participate and failed to provide crucial documentation, as reported by Latestly. The plaintiff’s attorney states the case has caused him severe personal and professional devastation and that he has PTSD.
Abuse alleged begins after plaintiff joins JPMorgan
March 2024
The complaint states that the alleged abuse began shortly after the plaintiff joined JPMorgan's Leveraged Finance division in March 2024 and escalated over time, with Lorna Hajdini identified as the primary accused.